The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's DiseaseJOURNAL OF ALZHEIMERS DISEASEIF3.12024-05-141PRE
Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer's DiseaseJOURNAL OF ALZHEIMERS DISEASEIF3.12022-08-023OAAI
Higher thyroid function is associated with accelerated hippocampal volume loss in Alzheimer's diseasePSYCHONEUROENDOCRINOLOGYIF3.62022-05-018OAAI
Altered thyroid hormone profile in patients with Alzheimer's diseasePSYCHONEUROENDOCRINOLOGYIF3.62020-11-0124OAAI
Patients with Alzheimer's Disease Have Increased Levels of Insulin-like Growth Factor-I in Serum but not in Cerebrospinal FluidJOURNAL OF ALZHEIMERS DISEASEIF3.12020-05-0512PREAI
Low serum concentration of free triiodothyronine (FT3) is associated with increased risk of Alzheimer's diseasePSYCHONEUROENDOCRINOLOGYIF3.62019-01-0131PREAI
Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementiaPSYCHONEUROENDOCRINOLOGYIF3.62017-12-0122PREAI
Stigma and Burden Among Relatives of Persons With Schizophrenia: Results From the Swedish COAST StudyPSYCHIATRIC SERVICESIF3.22015-10-0123OAAI
Stigma, discrimination and medication adherence in schizophrenia: Results from the Swedish COAST studyPSYCHIATRY RESEARCHIF3.92014-12-0140PREAI
HOW TO PREDICT AND MEASURE MEDICATION ADHERENCE IN SCHIZOPHRENIA: TWELVE MONTHS OF ELECTRONIC MONITORING (MEMS®) IN THE SWEDISH COAST-STUDYSCHIZOPHRENIA RESEARCHIF3.52014-04-010PREAI
Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS®) in the Swedish COAST-studyEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72013-12-0159PREAI
Thyroid Hormones Are Associated with Poorer Cognition in Mild Cognitive ImpairmentDEMENTIA AND GERIATRIC COGNITIVE DISORDERSIF1.92010-08-2628OAAI